Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Cellular and Molecular Life Sciences : CMLS
|
February 21, 2022
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Russel J Reiter, Ramaswamy Sharma, Fedor Simko, et al.
Vascular Pharmacology
|
June 15, 2015
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Raffaele Piccolo, Ingo Eitel, Gennaro Galasso, et al.
The American Journal of Cardiology
|
October 21, 2016
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction
Raffaele Piccolo, Gennaro Galasso, Ingo Eitel, et al.
The American Journal of Cardiology
|
September 7, 2014
Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Raffaele Piccolo, Gennaro Galasso, Allan Zeeberg Iversen, et al.
The American Journal of Cardiology
|
June 25, 2017
Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial)
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Jose M de la Torre-Hernandez, et al.
Journal of Pineal Research
|
October 14, 2016
Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Jose M de la Torre-Hernandez, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 13, 2022
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
Giuseppe Patti, Fabrizio D'Ascenzo, Ovidio De Filippo, et al.
Lancet (London, England)
|
January 17, 2021
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
Fabrizio D'Ascenzo, Ovidio De Filippo, Guglielmo Gallone, et al.
Lancet (London, England)
|
September 2, 2025
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
Xavier Rossello, Eva Irene Bossano Prescott, Anna Meta Dyrvig Kristensen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 5, 2021
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
Xavier Rossello, Sergio Raposeiras-Roubin, Roberto Latini, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Cellular and Molecular Life Sciences : CMLS
|
February 21, 2022
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Russel J Reiter, Ramaswamy Sharma, Fedor Simko, et al.
Vascular Pharmacology
|
June 15, 2015
Intracoronary abciximab in diabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Raffaele Piccolo, Ingo Eitel, Gennaro Galasso, et al.
The American Journal of Cardiology
|
October 21, 2016
Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction
Raffaele Piccolo, Gennaro Galasso, Ingo Eitel, et al.
The American Journal of Cardiology
|
September 7, 2014
Effects of baseline coronary occlusion and diabetes mellitus in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Raffaele Piccolo, Gennaro Galasso, Allan Zeeberg Iversen, et al.
The American Journal of Cardiology
|
June 25, 2017
Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial)
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Jose M de la Torre-Hernandez, et al.
Journal of Pineal Research
|
October 14, 2016
Effect of intravenous and intracoronary melatonin as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: Results of the Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty trial
Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Jose M de la Torre-Hernandez, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
January 13, 2022
Safety and efficacy of different P2Y12 inhibitors in patients with acute coronary syndromes stratified by the PRAISE risk score: a multicentre study
Giuseppe Patti, Fabrizio D'Ascenzo, Ovidio De Filippo, et al.
Lancet (London, England)
|
January 17, 2021
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets
Fabrizio D'Ascenzo, Ovidio De Filippo, Guglielmo Gallone, et al.
Lancet (London, England)
|
September 2, 2025
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
Xavier Rossello, Eva Irene Bossano Prescott, Anna Meta Dyrvig Kristensen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy
|
August 5, 2021
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
Xavier Rossello, Sergio Raposeiras-Roubin, Roberto Latini, et al.
Page
of 17